About Us  |  Contact Us  |  Feedback  |  Portfolio  |  Press  |  Advertise  |  Careers  |  Sitemap 
Medindia
   
   Google Search   Advanced Search
Web Medindia   
Health News RSSHealth news
Disease News RSSDisease News
SubscribeSubscribe
Login
Password
Forgot Password   New User
Medindia On MobileMedindia On Mobile Buy Health ProductsBuy Health Products
Medindia » Latest Health News » New Transgenic Mushrooms Raise Hope for Mass Production of Human Drugs
Latest Headlines
'Mouse' Turns 40 Today! (5 hrs ago)
Pregnant Women With Gestational Diabetes Mellitus on the Rise (6 hrs ago)
Chemical In Paint Could Promote Obesity: Study (6 hrs ago)
'Nayana' - A Unique Mobile Eye Care Initiative For Diabetics (6 hrs ago)
New Method That Helps Reduce Breast-lesion Biopsies Developed (6 hrs ago)
'Doctor At Your Doorstep' Becomes A Reality In Chunampet (6 hrs ago)
Antibiotics Blamed For Drug-induced Liver Injury (6 hrs ago)
All Latest News
News - Quick Links
News Central
Latest Health News
News Category
Popular News
Health News and Press Release
Special Reports
Health Watch
Health In Focus
Breaking Health News
Celebrating Life
Medindia - Exclusive
India Special
Lifestyle and Wellness
Popular News Topics
Drug News    Subscribe
Posted online: Sunday, June 24, 2007 at 1:34:16 PM
Font Size

New Transgenic Mushrooms Raise Hope for Mass Production of Human Drugs

Penn State and Agariger, Inc. have patented the technology of making new transgenic mushrooms, which have increased hope of using mushrooms for the mass production of commercially valuable proteins or useful human drugs.



The technology was introduced by a team of researchers including Charles Peter Romaine and Xi Chen at Penn State.

As part of the study, scientists developed a technique to genetically modify Agaricus bisporus, which is the predominant edible species worldwide by attaching a gene that confers resistance to hygromycin, an antibiotic, to circular pieces of bacterial DNA called plasmids, which have the ability to multiply within a bacterium known as Agrobacterium.

The hygromycin resistance gene was a marker gene to help sort out the transgenic mushroom cells from the non-transgenic cells.

Scientists then cut small pieces off the mushroom's gill tissue and added it to a flask containing the altered bacterium. Over the course of several days, as the bacterium went through its lifecycle, it transferred a portion of its plasmid into the mushroom cell, and integrated the introduced gene into the chromosome of the mushroom.

The researchers then exposed the mushroom cells to hygromycin. The antibiotic killed all the normal cells, separating out those that had been genetically altered for resistance.

The study demonstrated that if a second gene, insulin for example, were to be patched in the plasmid, that gene would be expressed as well.

"There is a high probability that if the mushroom cell has the hygromycin resistance gene, it will also have the partner gene," Romaine said.
Page 1 Page 1 | 2  Next

 Related Links
Medindia on Much Room for Cancer Cure in a Mushroom, Scientists Promise
Cure for cancer has sprung from an inconspicuous mushroom that cannot be swept away. Now, scientists in the United Kingdom, convinced of its promise, are getting ready to conduct clinical trials of drugs extracted from a variety of mushrooms, which could be a possible treatment for cancer.

Read More...

For More Information
Mushroom Extract Protects Poultry From Parasite Diseases
A Mushroom Extract May Impact the Body’s Immune System
 
 Share this News with:
Digg It
Digg
Del.icio.us
Del.icio.us
Stumbleupon
StumbleUpon
Google
Google
Windows Live
Windows Live
NewsVine
Newsvine
Reddit
Reddit
Post Your Comments
Be the first to comment
* Name
   (For display)
* Email
* Your Email address will not be displayed on the site or used to send unsolicited e-mails.
* Comment
* Your comment can be maximum of 2500 characters
           

Please keep your comments short, relevant and to the point
Do not use objectionable language
Do not provide personal information in the comments
Drug Related News
Antibiotics Blamed For Drug-induced Liver Injury
Nifedipine Shows No Benefit in Preventing Pre-mature Birth
Dutch Court Rejects Bid Against 'Magic Mushroom' Ban
Experimental Drug Shows Promise Against Latent TB Bacteria
New Class of Cholesterol-lowering Drugs Developed
Read More

 News Archive

 Search by Keyword


Web Medindia  Advanced Search
Feedback
Last Updated - - Designed & Content Managed by Medindia Health Network Pvt Ltd. Hosted & Technical Support by FrontPoint Systems
DisclaimerThe contents of this site are for informational purposes only. Always seek the advice of a qualified physician for any doubts.
To Read full Disclaimer Click Here!
Best viewed with resolution 1024x768 px.
Advertise with us |  Medindia Copyright |  Privacy Policy |  © All Rights Reserved 1997 - 2008